Interleukin-12 Gene in Treating Patients With Liver Metastases Secondary to Colorectal Cancer - Contacts and Locations

Home

Interleukin-12 Gene in Treating Patients With Liver Metastases Secondary to Colorectal Cancer

This study is currently recruiting participants.

Study NCT00072098. Last updated on July 23, 2008. Information provided by National Cancer Institute (NCI)

Please refer to this study by its ClinicalTrials.gov identifier: NCT00072098

Locations


United States, New York
	Mount Sinai Medical Center	Recruiting
	New York, New York, United States, 10029
	Contact: Max W. Sung, MD 212-241-7902 max.sung@mssm.edu

Sponsors and Collaborators

Mount Sinai School of Medicine

National Cancer Institute (NCI)

Investigators


Principal Investigator:	Max W. Sung, MD	Mount Sinai School of Medicine